Keeping it Brief: Financial Toxicity

Topic Overview We all know it:  cancer is expensive. It’s not a secret that people find it difficult to afford their prescription medications – especially cancer patients facing the expenses of specialty drugs. An average patient can expect out-of-pocket expenses to be between 20% to 30%….

Read Full Post

Partial Fix for Unexpected Colonoscopy Charges

Some people who go in for a routine screening colonoscopy (fully covered by most insurance) can end up with a surprise bill of several hundred dollars, if the doctor detected and removed one or more polyps. Under current law, Medicare beneficiaries must pay a coinsurance when…

Read Full Post

Memorial Sloan-Kettering Will Not Offer Zaltrap

Memorial Sloan-Kettering Cancer Center made a very public announcement—and explanation—today in a New York Times op-ed about why they will not offer the new drug Zaltrap® (ziv-aflibercept) to its metastatic colorectal cancer patients. The authors, all world-renowned cancer specialists at the world’s oldest cancer center, in…

Read Full Post

Oldest of Old Americans Will Drastically Impact U.S. Cancer Care

The numbers are stark and will touch every single American. A picture of cancer in the greying American population was drawn in a recent study in the Journal of Geriatric Oncology examining trends in the National Cancer Institute’s population-based SEER data: The number of “oldest of the old”…

Read Full Post

New Help with the Tough Struggle with Cancer Costs

Difficulty managing the cost of their cancer care stressed three out of four patients, according to a study recently completed by the Cancer Support Community.  In addition two out of three said their health care team didn’t discuss financial aspects of care with them. In…

Read Full Post